Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cytosorbents Corp - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
CTSO
Nasdaq
3845
https://cytosorbents.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cytosorbents Corp
These Analysts Think Cytosorbents Corporation's (NASDAQ:CTSO) Sales Are Under Threat
- Mar 20th, 2024 10:21 am
Cytosorbents Full Year 2023 Earnings: Misses Expectations
- Mar 16th, 2024 12:20 pm
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript
- Mar 15th, 2024 2:14 pm
Q4 2023 Cytosorbents Corp Earnings Call
- Mar 15th, 2024 10:28 am
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
- Mar 14th, 2024 8:39 pm
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
- Mar 6th, 2024 12:00 pm
Cytosorbents (NASDAQ:CTSO) investors are sitting on a loss of 90% if they invested three years ago
- Feb 23rd, 2024 10:11 am
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
- Feb 8th, 2024 12:00 pm
CTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.
- Jan 17th, 2024 2:42 pm
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
- Jan 17th, 2024 12:15 pm
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
- Dec 28th, 2023 12:00 pm
Insider Spends US$100k Buying More Shares In Cytosorbents
- Dec 18th, 2023 11:10 am
Insider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)
- Dec 16th, 2023 12:01 pm
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
- Dec 13th, 2023 2:15 pm
CTSO: CytoSorbents reports 3rd quarter 2023 financial and operating results which showed strong product revenue growth and an improved cost structure.
- Nov 14th, 2023 1:10 pm
Q3 2023 Cytosorbents Corp Earnings Call
- Nov 10th, 2023 2:42 pm
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript
- Nov 10th, 2023 1:52 pm
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
- Nov 9th, 2023 9:15 pm
CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
- Oct 27th, 2023 11:00 am
CytoSorbents to Present at the 8th Annual Dawson James Conference
- Oct 5th, 2023 11:00 am
Scroll